G
Galen H. Fisher
Researcher at National Institutes of Health
Publications - 10
Citations - 3707
Galen H. Fisher is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Fas receptor & Fas ligand. The author has an hindex of 8, co-authored 10 publications receiving 3626 citations.
Papers
More filters
Journal ArticleDOI
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
Galen H. Fisher,Fredric J Rosenberg,Sharon E. Straus,Janet K. Dale,Lindsay A. Middelton,Albert Y. Lin,Warren Strober,Michael J. Lenardo,Jennifer M. Puck +8 more
TL;DR: The occurrence of Fas mutations together with abnormal T cell apoptosis in ALPS patients suggests an involvement of Fas in this recently recognized disorder of lymphocyte homeostasis and peripheral self-tolerance.
Journal ArticleDOI
Induction of apoptosis in mature T cells by tumour necrosis factor.
Lixin Zheng,Galen H. Fisher,Robert E. Miller,Jacques J. Peschon,David H. Lynch,Michael J. Lenardo +5 more
TL;DR: It is shown that tumour necrosis factor (TNF) can mediate mature T-cell receptor-induced apoptosis through the p75 TNF receptor and suggest that autoregulatory apoptosis of the mature T cells can occur by two distinct molecular mechanisms.
Journal ArticleDOI
Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes
Galen H. Fisher,Shari L. Wellen,David S. Klimstra,Joi M. Lenczowski,Jay W. Tichelaar,Martin J. Lizak,Jeffrey A. Whitsett,Alan P. Koretsky,Harold E. Varmus +8 more
TL;DR: Transgenic mice that express murine K-Ras4b(G12D) under the control of doxycycline in type II pneumocytes show that the appearance and regression of these pulmonary tumors can be readily monitored in anesthetized transgenic animals by magnetic resonance imaging.
Journal ArticleDOI
Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.
David A. Martin,Lixin Zheng,Richard M. Siegel,Baohua Huang,Galen H. Fisher,Jin Wang,Christine E. Jackson,Jennifer M. Puck,Janet K. Dale,Sharon E. Straus,Marcus E. Peter,Peter H. Krammer,Stephen W. Fesik,Michael J. Lenardo +13 more
TL;DR: It is suggested that intracytoplasmic CD95 mutations in ALPS impair apoptosis chiefly by disrupting death-domain interactions with the signaling protein FADD/MORT1.
Journal ArticleDOI
Development of a flexible and specific gene delivery system for production of murine tumor models.
Galen H. Fisher,Sandra Orsulic,Eric C. Holland,Wendy P. Hively,Yi Li,Brian C. Lewis,Bart O. Williams,Harold E. Varmus +7 more
TL;DR: To develop models of human cancer, the avian retroviral receptor, TVA, is expressed under a variety of mammalian promoters in transgenic mice, thus rendering mice susceptible to infection with avian leukosis virus-derived gene vectors.